Change in Albuminuria in Patients with ANCA-Associated Vasculitis Treated with Avacopan

被引:0
|
作者
Geetha, Duvuru [1 ]
Cortazar, Frank [2 ]
Karras, Alexandre [3 ]
Bruchfeld, Annette [4 ]
Yue, Huibin [5 ]
Merkel, Peter [6 ]
Jayne, David [7 ]
机构
[1] Johns Hopkins Univ, Baltimore, MD USA
[2] New York Nephrol, Watervliet, NY USA
[3] HEGP APHP, Paris, France
[4] Karolinska Inst, Stockholm, Sweden
[5] Amgen Inc, Thousand Oaks, CA USA
[6] Univ Penn, Philadelphia, PA USA
[7] Univ Cambridge, Cambridge, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0857
引用
收藏
页码:1719 / 1721
页数:3
相关论文
共 50 条
  • [31] Avacopan bei ANCA-assoziierter Vaskulitis – für wen?Avacopan in ANCA-associated vasculitis—for whom?
    Kirsten de Groot
    Die Nephrologie, 2023, 18 (3) : 182 - 185
  • [32] Avacopan as an add-on therapy for ANCA-associated vasculitis: a pharmacological overview
    Tesar, Vladimir
    Hartinger, Jan Miroslav
    Hruskova, Zdenka
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2024,
  • [33] Efficacy and safety of avacopan in patients with ANCA-associated vasculitis receiving rituximab in a randomised trial
    Geetha, Duvuru
    Dua, Anisha
    Yue, Huibin
    Springer, Jason
    Salvarani, Carlo
    Jayne, David
    Merkel, Peter
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (02) : 223 - 232
  • [34] Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan
    Cortazar, Frank B.
    Niles, John L.
    Jayne, David R. W.
    Merkel, Peter A.
    Bruchfeld, Annette
    Yue, Huibin
    Schall, Thomas J.
    Bekker, Pirow
    KIDNEY INTERNATIONAL REPORTS, 2023, 8 (04): : 860 - 870
  • [35] EFFICACY AND SAFETY OF AVACOPAN IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS RECEIVING RITUXIMAB IN THE ADVOCATE TRIAL
    Geetha, D.
    Dua, A.
    Yue, H.
    Salvarani, C.
    Jayne, D.
    Merkel, P. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 338 - 339
  • [36] In ANCA-associated vasculitis, avacopan was superior to prednisone taper for sustained remission
    Khan, Mubeen M.
    Molony, Donald A.
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (07) : JC79 - JC79
  • [37] Is it possible to use avacopan alone in the induction of remission in ANCA-associated vasculitis?
    Kubota, Soichiro
    Hanai, Shunichiro
    Tanaka-Mabuchi, Nakako
    Ito, Ryosuke
    Nakagomi, Daiki
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2024, 8 (03)
  • [38] COST-UTILITY ANALYSIS OF AVACOPAN FOR THE TREATMENT OF ANCA-ASSOCIATED VASCULITIS (AAV) PATIENTS IN THE UK
    Serna, Ramirez de Arellano A.
    Berdunov, V
    Baxter, G.
    VALUE IN HEALTH, 2022, 25 (12) : S130 - S130
  • [39] Avacopan for ANCA-Associated Vasculitis in Ireland: A Report on All Patients Who Received Avacopan in the Irish Health Care System
    Nic an Riogh, Eithne Muireann
    Cummiskey, Andy Gerard
    Stoneman, Sinead
    Clarkson, Michael
    Moran, Sarah Margaret
    Magee, Ciara N.
    McAnallen, Susan Marie
    Little, Mark Alan
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [40] SEVERE INFECTIONS IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS TREATED WITH RITUXIMAB
    Segelmark, Leo
    Felipe Flores-Suarez, Luis
    Rathmann, Jens
    Mohammad, Aladdin
    RHEUMATOLOGY, 2019, 58